Teflaro Side Effects

During research on Teflaro, side effects were closely monitored and documented. Some of the most commonly reported problems seen with this drug included diarrhea, nausea, and a rash. This prescription antibiotic was also shown to cause potentially serious reactions, such as seizures, bloody diarrhea, and a dangerous form of anemia.

 

An Introduction to Teflaro Side Effects

Just like any medicine, Teflaro® (ceftaroline fosamil) can cause side effects. However, not everyone who receives the drug will have problems. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Teflaro. Your healthcare provider can discuss a more complete list with you.)
 

Common Side Effects of Teflaro

Teflaro has been studied extensively in clinical trials. In these studies, the side effects that occurred in a group of people given Teflaro were documented and compared to those that occurred in a similar group of people who received other antibiotics.
 
Based on these studies, the most common Teflaro side effects included:
 
  • Diarrhea -- in up to 5 percent of people
  • Nausea -- up to 4 percent
  • Rash -- up to 3 percent
  • Constipation -- up to 2 percent
  • Vomiting -- up to 2 percent
  • Low blood potassium levels (hypokalemia) -- up to 2 percent
  • Increased liver enzymes (found using standard blood tests) -- up to 2 percent
  • Inflammation of a vein (phlebitis) -- up to 2 percent.
 

Teflaro Antibiotic Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.